GlassScriptPhysician profile
Joseph Lightsey
NPI 1033522990
$44,575.73
in general payments reported to CMS, 2019-2025
30 companies · $5,886 in 2025
The $5,886 reported for 2025 was more than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,026 · 2020: $1,909 · 2021: $14K · 2022: $11K · 2023: $5,135 · 2024: $5,958 · 2025: $5,886.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $10K · Food and Beverage: $6,525.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $10,454.00 |
| Food and Beverage | $6,524.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $31,658.48 | 2021-2025 | Evera Mri Xt Dr Surescan, Diamondtemp Bidirectional Ablation Catheter, Aurora Ev-Icd Mri Surescan |
| Boston Scientific Corporation | $5,364.25 | 2019-2025 | Farapulse, Ingevity+, Sq-Rx Pulse Generator |
| Biosense Webster, INC. | $2,181.45 | 2021-2025 | Carto 3, Octaray Mapping Catheter |
| Biotronik INC. | $1,554.10 | 2019-2020 | |
| Philips North America LLC | $807.78 | 2023 | |
| Abbott Laboratories | $603.27 | 2019-2024 | Ensite, Advisor |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $438.21 | 2019-2023 | Lifevest |
| Pfizer INC. | $317.28 | 2019-2025 | |
| Cardiva Medical, INC. | $278.39 | 2022-2025 | Cardiva Vascade Mvp Vvcs 6-12f, Cardiva Vascade Mvp Xl Vvcs 10-12f |
| Novartis Pharmaceuticals Corporation | $260.95 | 2019-2020 | |
| Lantheus Medical Imaging, INC. | $130.95 | 2019 | |
| Janssen Pharmaceuticals, INC | $127.88 | 2019-2023 | Xarelto |
| Amgen INC. | $114.91 | 2019-2021 | |
| Btg International INC. | $100.80 | 2019 | |
| Abiomed | $90.30 | 2025 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Braemar Manufacturing, LLC | $72.78 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $69.56 | 2019-2021 | |
| Stereotaxis INC | $59.67 | 2022 | |
| Edwards Lifesciences Corporation | $48.10 | 2024 | Hemosphere |
| E.R. Squibb & Sons, L.L.C. | $38.87 | 2021-2022 | |
| Actelion Pharmaceuticals US, INC. | $38.81 | 2020 | |
| United Therapeutics Corporation | $37.48 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $33.47 | 2019 | |
| Kestra Medical Technology Services, INC. | $32.55 | 2024 | Assure Wcd |
| Innovation Technologies INC | $24.94 | 2025 | Irrisept |
| Acist Medical Systems, INC. | $24.18 | 2024 | |
| Astellas Pharma US INC | $22.96 | 2020 | |
| Akcea Therapeutics, INC. | $15.39 | 2019 | |
| Cardiovascular Systems INC. | $15.08 | 2021 | |
| Vifor Pharma, INC. | $12.89 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Lightsey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.